04.01.15
Dallas, Texas-based Bone Solutions Inc. has appointed a new CEO. Drew M. Diaz has worked in the healthcare field for more than 27 years, most recently serving five years as co-founder and CEO of Heart Test Laboratories Inc., a U.S. cardiology device company.
Prior to Heart Test Laboratories, Diaz was senior vice president of global sales for Criticare Systems Inc., a U.S. manufacturer of anesthesia, cardiac and patient monitoring equipment. He has held positions with various Fortune 500 companies, including IBM, Pfizer Inc., and DeRoyal Industries throughout his career.
Diaz has experience and knowledge of domestic and international medical device management in addition to a deep understanding of development and strategic planning of medical exports, according to the company. Well versed in international trade and management, Diaz has managed offices in Brazil, China, Germany, India, and the United States. As the managing director and president of Medical Logistics GmbH, a medical device company in Bad Homburg, Germany, Diaz was responsible for the administration, engineering, technical support and all sales and marketing.
Diaz is a board member of three medical organizations in the United States. He is a graduate of Texas A&M University and has attended Harvard University Business School Executive Training.
“We are extremely proud to announce a president of Drew Diaz’s caliber and expertise,” said Tom Lally, founder and executive chairman of Bone Solutions Inc. “I look forward to working in hand with Drew to continue to elevate BSI’s national profile and provide orthopedic surgeons a means to improve clinical outcomes in a number of complex procedures, while lowering costs.”
Bone Solutions’ flagship product is Osteocrete, a proprietary bone void filler product cleared in 2009.
Prior to Heart Test Laboratories, Diaz was senior vice president of global sales for Criticare Systems Inc., a U.S. manufacturer of anesthesia, cardiac and patient monitoring equipment. He has held positions with various Fortune 500 companies, including IBM, Pfizer Inc., and DeRoyal Industries throughout his career.
Diaz has experience and knowledge of domestic and international medical device management in addition to a deep understanding of development and strategic planning of medical exports, according to the company. Well versed in international trade and management, Diaz has managed offices in Brazil, China, Germany, India, and the United States. As the managing director and president of Medical Logistics GmbH, a medical device company in Bad Homburg, Germany, Diaz was responsible for the administration, engineering, technical support and all sales and marketing.
Diaz is a board member of three medical organizations in the United States. He is a graduate of Texas A&M University and has attended Harvard University Business School Executive Training.
“We are extremely proud to announce a president of Drew Diaz’s caliber and expertise,” said Tom Lally, founder and executive chairman of Bone Solutions Inc. “I look forward to working in hand with Drew to continue to elevate BSI’s national profile and provide orthopedic surgeons a means to improve clinical outcomes in a number of complex procedures, while lowering costs.”
Bone Solutions’ flagship product is Osteocrete, a proprietary bone void filler product cleared in 2009.